ED
RAI

Exane Derivatives’s Reynolds American Inc RAI Stock Holding History

Exane Derivatives’s Portfolio RAI Stock Details RAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-92,603
Closed -$6.02M – 673
2017
Q2 		$6.02M Buy
+92,603
New +$6.05M 1.29% 13
2017
Q1 		– Sell
-14,143
Closed -$792K – 709
2016
Q4 		$792K Sell
14,143
-5,136
-27% -$273K 0.16% 104
2016
Q3 		$909K Sell
19,279
-239,605
-93% -$12M 0.14% 98
2016
Q2 		$14M Sell
258,884
-9,561
-4% -$481K 2.31% 4
2016
Q1 		$13.5M Buy
268,445
+151,328
+129% +$7.43M 1.79% 28
2015
Q4 		$5.4M Buy
+117,117
New +$5.42M 0.74% 39
2015
Q3 		– Sell
-548,632
Closed -$22.8M – 579
2015
Q2 		$20.5M Buy
+548,632
New +$20.5M 2.2% 25
2015
Q1 		– Sell
-154,482
Closed -$5.41M – 570
2014
Q4 		$4.96M Buy
+154,482
New +$4.89M 0.69% 41

Other funds holding RAI

WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
MDCM
Morgan Dempsey Capital Management Menomonee Falls, Wisconsin $220M AUM 18.32% 1-Year Est. Return

Exane Derivatives's RAI Position: Q3 2017 in Review

Exane Derivatives sold out of Reynolds American Inc (RAI) in Q3 2017, closing a stake of 92,603 shares — an estimated $6.02M sold.

Exane Derivatives first reported a position in RAI in Q4 2014 and held it in 8 quarters. The position peaked at $20.5M in Q2 2015. 3 funds tracked by Wall St. Rank hold RAI as of Q3 2017.

  • Exane Derivatives reported no remaining Reynolds American Inc position as of Q3 2017 after selling out during the quarter.
  • Exane Derivatives sold 92,603 Reynolds American Inc shares in Q3 2017, an estimated $6.02M.
  • Exane Derivatives first reported a position in Reynolds American Inc in Q4 2014 and held it in 8 quarters.
  • Exane Derivatives's Reynolds American Inc position peaked at $20.5M in Q2 2015.
  • 3 funds tracked by Wall St. Rank held Reynolds American Inc as of Q3 2017.

Based on Exane Derivatives's 13F filing for Q3 2017, filed 18 Oct 2017.